Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Retatrutide is currently in clinical trials and not yet approved by Health Canada or the FDA for general use
Published meta-analyses and systematic reviews indicate that both oral and injectable GLP-1 RAs delay gastric emptying, but the magnitude of this effect is similar across formulations when matched for agent and dosing schedule
It's designed to manage blood sugar levels in adults with type 2 diabetes
Saxenda Dosing Saxenda requires daily subcutaneous injection: Titration schedule: Administration: Inject once daily at any time Consistent timing recommended Abdomen, thigh, or upper arm injection sites Rotate sites to prevent irritation Practical burden: 365 injections per year Must remember daily More needle/supply use Higher chance of missed doses Semaglutide Dosing Semaglutide requires weekly subcutaneous injection: Titration schedule (Wegovy doses): Administration: Inject once weekly on the same day each week Any time of day Same injection sites as Saxenda Rotate sites Practical burden: 52 injections per year Weekly reminder easier than daily Less needle/supply use Better adherence typically Dosing Comparison Impact on Adherence Research consistently shows better adherence with weekly versus daily medications: Daily dosing challenges: Easier to forget More disruption to routines Higher cumulative burden Greater chance of inconsistent dosing Weekly dosing advantages: Easier to remember one day Less intrusion on daily life Can establish reliable routine Fewer opportunities to miss doses Better adherence translates to better real-world results
One 2020 study looked at the connection between these two conditions and higher amounts of dairy consumption, especially whole-fat varieties
In particular, children aged 5-12 years and children with overweight rather than obesity profit from lifestyle interventions [33]
